₹47.3*
MRP ₹52.5
10% off
₹44.62*
MRP ₹52.5
15% CB
₹7.88 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Prescription drugWhats That
Composition :
ACETYLCYSTEINE-200MG/ML
Manufacturer/Marketer :
AAA Pharma Trade Pvt Ltd
Consume Type :
PARENTERAL
Return Policy :
Not Returnable
Expires on or after :
Drug-Drug Interactions
No Drug - Drug interactions found in our data. We may lack specific data on this medicine and are actively working to update our database. Consult your doctor for personalized advice
Drug-Drug Interactions
Login/Sign Up
Drug-Food Interactions
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Food Interactions
Login/Sign Up
Mucomyks 400Mg/2Ml Inj Substitute
Mucomeg 200 mg Injection 2 ml
by Others
₹26.10per tabletMucomix Injection 1 ml
by Others
₹26.00per tabletLC-Mist 20% Injection
by Others
₹22.05per tablet
Product Substitutes
Author Details
_0.jpg?tr=q-80,f-webp,w-100,dpr-6,c-at_max)
Drug-Diseases Interactions
ACETYLCYSTEINE-200MG/MLHepatic failure, not elsewhere classified
Severe
ACETYLCYSTEINE-200MG/MLAsthma
Moderate
Drug-Diseases Interactions
Login/Sign Up
ACETYLCYSTEINE-200MG/MLHepatic failure, not elsewhere classified
Severe
How does the disease interact with Mucomyks 400Mg/2Ml Inj:
For individuals who have encephalopathy brought on by hepatic failure, the use of Mucomyks 400Mg/2Ml Inj should be stopped in order to prevent further nitrogenous material ingestion.
How to manage the interaction:
Mucomyks 400Mg/2Ml Inj should be discontinued in patients with encephalopathy (permanent or temporary brain damage) due to liver failure.
For individuals who have encephalopathy brought on by hepatic failure, the use of Mucomyks 400Mg/2Ml Inj should be stopped in order to prevent further nitrogenous material ingestion.
How to manage the interaction:
Mucomyks 400Mg/2Ml Inj should be discontinued in patients with encephalopathy (permanent or temporary brain damage) due to liver failure.
ACETYLCYSTEINE-200MG/MLAsthma
Moderate
How does the disease interact with Mucomyks 400Mg/2Ml Inj:
When treating asthmatic patients or situations where bronchospasm has occurred in the past, Mucomyks 400Mg/2Ml Inj should be administered cautiously. When starting and continuing Mucomyks 400Mg/2Ml Inj medication, patients with asthma should be closely monitored.
How to manage the interaction:
Mucomyks 400Mg/2Ml Inj should be used with caution in asthma patients or where there is a history of bronchospasm (tightening of muscles lining airways). Asthma patients should be closely monitored during the initiation of and throughout Mucomyks 400Mg/2Ml Inj therapy.
When treating asthmatic patients or situations where bronchospasm has occurred in the past, Mucomyks 400Mg/2Ml Inj should be administered cautiously. When starting and continuing Mucomyks 400Mg/2Ml Inj medication, patients with asthma should be closely monitored.
How to manage the interaction:
Mucomyks 400Mg/2Ml Inj should be used with caution in asthma patients or where there is a history of bronchospasm (tightening of muscles lining airways). Asthma patients should be closely monitored during the initiation of and throughout Mucomyks 400Mg/2Ml Inj therapy.
ACETYLCYSTEINE-200MG/MLOther disorders of fluid, electrolyte and acid-base balance
Moderate
How does the disease interact with Mucomyks 400Mg/2Ml Inj:
Mucomyks 400Mg/2Ml Inj administered intravenously may lead to fluid overload, which may result in hyponatremia, seizures, and even death.
How to manage the interaction:
To avoid fluid overload, a diluted dose is recommended, especially in patients less than 40 kg and those requiring fluid restrictions.
Mucomyks 400Mg/2Ml Inj administered intravenously may lead to fluid overload, which may result in hyponatremia, seizures, and even death.
How to manage the interaction:
To avoid fluid overload, a diluted dose is recommended, especially in patients less than 40 kg and those requiring fluid restrictions.
ACETYLCYSTEINE-200MG/MLOther diseases of digestive system
Moderate
How does the disease interact with Mucomyks 400Mg/2Ml Inj:
Mucomyks 400Mg/2Ml Inj use may make vomiting worse. The risk of gastrointestinal haemorrhage should be assessed in patients with peptic ulcer disease.
How to manage the interaction:
Patients with peptic ulcer disease should be evaluated for the risk of gastrointestinal bleeding. In case of gastric haemorrhage, Mucomyks 400Mg/2Ml Inj is advised if your doctor considers benefit for you is greater than risk.
Mucomyks 400Mg/2Ml Inj use may make vomiting worse. The risk of gastrointestinal haemorrhage should be assessed in patients with peptic ulcer disease.
How to manage the interaction:
Patients with peptic ulcer disease should be evaluated for the risk of gastrointestinal bleeding. In case of gastric haemorrhage, Mucomyks 400Mg/2Ml Inj is advised if your doctor considers benefit for you is greater than risk.
